Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh.

Follow along as we build a weight loss tracker in Google Sheets from scratch. You’ll learn how to enter goals, log progress, adjust charts, and print your tracker for an easy way to stay on top of ...

Vitamin B12 for weight loss: Does it work? Since the dawn of the Internet (and probably well before), there have been several solutions sold for weight management — including vitamins for weight loss.

The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva Pharmaceuticals announced Thursday. The generic form of liraglutide (Saxenda) is ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

INDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival ...

The demand for weight loss operations dropped sharply last year as the number of people opting for anti-obesity drugs such as Wegovy and Saxenda more than doubled, a study published Friday found. The ...

Novo Nordisk has earnt yet another dressing down from the PMCPA. The U.K. self-regulatory body found fault with Novo’s support for U.K pharmacy chains’ weight management services, leading its panel to ...

A drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study shows. Liraglutide lowered body mass, ...